AVAH vs CLOV: fair value comparison
Aveanna Healthcare Holdings Inc. and Clover Health Investments, Corp. · Updated 2026-10-19
CLOV's estimate rests on a sector-average multiple, which TickrTrends does not publish as a verdict. Within Healthcare, AVAH currently ranks higher by quality score.
| AVAH | CLOV | |
|---|---|---|
| Verdict | Fairly valued | Awaiting full valuation |
| Last price | $12.34 | $4.48 |
| 12-month range | $6.22–$14.38 | $1.70–$5.41 |
| Rank by discount to fair value | #61 of 108 Healthcare | — |
| Rank by quality score | #147 of 301 Healthcare | #148 of 301 Healthcare |
| Quality grade | D | D |
| Leverage | High | — |
| Margin trend | Contracting | Contracting |
| Revenue growth | Strong | High |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | Uptrend |
| 52-week position | The top quarter | The upper-middle quarter |
Full single-stock breakdowns: AVAH fair value analysis · CLOV fair value analysis